Clinical Report: Advances in Identification and Management of Inherited Retinal Diseases
Overview
Recent breakthroughs in multimodal imaging, functional and genetic testing have enhanced the identification and management of inherited retinal diseases (IRDs) within optometric practice. The prevalence of IRDs in the United States has nearly doubled since 2016, underscoring the growing clinical relevance for eye care providers.
Background
Inherited retinal diseases (IRDs) are a group of genetic disorders that cause progressive vision loss and can be challenging to diagnose accurately. Advances in diagnostic technologies such as optical coherence tomography (OCT) and full-field electroretinography have improved detection and monitoring of these conditions. Genetic testing further aids in confirming diagnoses and guiding management strategies. Optometrists are increasingly positioned to provide comprehensive care, including low-vision services, for patients with IRDs.
Data Highlights
| Year | Prevalence of IRDs per 100,000 |
|---|---|
| 2016 | ~53 |
| 2023 | 106 |
Key Findings
- The prevalence of inherited retinal diseases in the U.S. has increased to 106 per 100,000 people in 2023, nearly double the rate reported in 2016.
- Multimodal imaging techniques like OCT and functional tests such as full-field electroretinography are effective, billable tools for IRD diagnosis and monitoring in optometric practice.
- Genetic testing can reveal true diagnoses in patients initially misdiagnosed with other retinal conditions, enabling targeted management.
- Low-vision services provided by optometrists significantly improve quality of life for patients with IRDs.
- Patient satisfaction with care leads to word-of-mouth referrals, expanding clinical practice opportunities in IRD management.
Clinical Implications
Optometrists should incorporate advanced imaging and genetic testing into their diagnostic protocols to accurately identify IRDs. Providing comprehensive management, including low-vision rehabilitation, can profoundly impact patient outcomes and satisfaction. Awareness of the increasing prevalence of IRDs highlights the importance of preparedness in routine clinical practice.
Conclusion
The evolving landscape of diagnostic and management tools presents a valuable opportunity for optometrists to enhance care for patients with inherited retinal diseases. Embracing these advances can improve patient quality of life and support practice growth.
References
- Abbass NJ et al. 2025 -- Trends and disparities in the incidence and prevalence of inherited retinal diseases in the United States
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.